Talk:Ursodeoxycholic acid: Difference between revisions

Content deleted Content added

Inline

Revision as of 19:25, 30 December 2022

This article has not yet been rated on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Mid	This article has been rated as Mid-importance on the project's importance scale.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Mid	This article has been rated as Mid-importance on the project's importance scale.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ursodeoxycholic acid.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Untitled

Would plant sterols have a similiar effect as it blocks the absorbtion of cholestorol?Interestedperson (talk) 14:38, 22 January 2009 (UTC)[reply]

Medical uses

This section reads terribly, just random bits of info about lack of evidence. Please could somebody who knows about this write a list of what it's currently used for; you can keep the info about the lack of evidence. Edit: Just added a list of some that I knew, with some sources to their use. Feel free to add more.

Expensive? Not so much...

Article says "The drug is very expensive". I am not sure when this was written or in what country it's referring to, but I just checked the wholesale cost, and one of the major US pharmacy wholesalers is charging $22.75 for 100 capsules (300mg) as of today. This seems eminently reasonable to me. If anyone wants to justify leaving this sentence in, have at it; otherwise I'm removing it in a week. Shalom S. (talk) 21:30, 2 May 2012 (UTC)[reply]

In Australia it is heavily subsidised by the Australian Government and can be purchased retail on special authority prescription (you have to be very ill) for AU$33 for 200 capsules. Otherwise it retails for AU$250 per 100. That makes it expensive. (At time of writing US$1.00 = AU$0.97) — Preceding unsigned comment added by 124.171.87.7 (talk) 09:40, 6 July 2012 (UTC)[reply]

Interpretation of Study

I just revised the section that previously stated that the use of this drug is associated with hepatocellular carcinoma (HCC, i.e. primary liver cancer) in those with Primary Biliary Cirrhosis (PBC) who don't respond to the drug, at an incidence of 20% after 15 years. This is not what the study (http://www.ncbi.nlm.nih.gov/pubmed/21389798) says.

All of the patients in the study had PBC. All of them were treated with the drug. The disease's natural course is to lead to cirrhosis, which, in turn, can lead to HCC. The drug is FDA-approved to slow the progression of the disease, but not everyone responds. Those who don't respond to the drug, by definition, experience the progression of the disease more quickly, and therefore experience a higher incidence of HCC. There's no evidence that the use of the drug itself was associated with HCC. For example, there was no control group of PBC-free patients who also took the drug. As previously written, then, the claim invited the inference that PBC patients who are non-responsive to the drug can reduce their HCC risk by simply discontinuing the drug, which is not at all what the study says. Hopefully the clarified text is more helpful. — Preceding unsigned comment added by 70.174.135.194 (talk) 22:10, 18 October 2014 (UTC)[reply]

Possible copyright problem

This article has been revised as part of a large-scale clean-up project of multiple article copyright infringement. (See the investigation subpage) Earlier text must not be restored, unless it can be verified to be free of infringement. For legal reasons, Wikipedia cannot accept copyrighted text or images borrowed from other web sites or printed material; such additions must be deleted. Contributors may use sources as a source of information, but not as a source of sentences or phrases. Accordingly, the material may be rewritten, but only if it does not infringe on the copyright of the original or plagiarize from that source. Please see our guideline on non-free text for how to properly implement limited quotations of copyrighted text. Wikipedia takes copyright violations very seriously. Moneytrees🌴^{Talk🌲Help out at CCI!} 21:52, 29 April 2020 (UTC)[reply]

Note that this seems to be a good edit and can be re-inserted. Moneytrees🌴^{Talk🌲Help out at CCI!} 21:52, 29 April 2020 (UTC)[reply]

I have reinserted many of the edits I did after this disruption. Further review will help! Jrfw51 (talk) 17:41, 30 April 2020 (UTC)[reply]

SARS-CoV-2 infection

Reference: “FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2” by Teresa Brevini, et al. From https://pubmed.ncbi.nlm.nih.gov/36470304/

Researchers have found that, " ...ursodeoxycholic acid (UDCA), an off-patent drug used to treat a form of liver disease known as primary biliary cholangitis...." may be a new way to prevent all variants of covid-19 infections in certain populations. 99.115.154.2 (talk) 05:57, 30 December 2022 (UTC)[reply]

@@ Line 33: / Line 33: @@
 == SARS-CoV-2 infection ==
-Reference: “FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2” by Teresa Brevini, et al.
+Reference: “FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2” by Teresa Brevini, et al. From https://pubmed.ncbi.nlm.nih.gov/36470304/
 Researchers have found that, " ...ursodeoxycholic acid (UDCA), an off-patent drug used to treat a form of liver disease known as primary biliary cholangitis...." may be a new way to prevent all variants of covid-19 infections in certain populations. [[Special:Contributions/99.115.154.2|99.115.154.2]] ([[User talk:99.115.154.2|talk]]) 05:57, 30 December 2022 (UTC)